6Marik PE, Pinsky M. Death by parenteral nutrition [J]. Intensive Care Med, 2003, 29 (6): 867-869.
7Ohta T, Elnemr A, Kitagawa H, et al, Fas Lignad expression in human pancreatic cancer [ J ]. Oncol Rep, 2004, 12 (4) : 749- 754.
8Lee TB, Min YD, Lim SC, et al. Fas (Apo-1/CD95) and Fas ligand interaction between gastiric cancer cells and irranune cells [ J ]. J Castroonterol Hepatol, 2002, 17 (1) : 32-38.
9Bennett MW, O' Connell J, O' sullivan GC, et al. Expression of Fas ligand by human gastric adenocarcinomas: a potential potential mechanism of immune ascape in stomach cancer [J]. Gut, 1999, 44 (2) : 156-162.
10Okada K, Kometa K, Hashimoto S, et al. Frequency of apoptosis of tumor-infiltrating lympbocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis [ J ]. Clin Cancer Res, 2000, 6 (9): 3560-3564.
